Gate Bioscience

Gate Bioscience is at the forefront of biotechnology research, pioneering a new class of medicines known as Molecular Gates. Located in Brisbane, CA, California, Gate Bioscience focuses on developing small molecule drugs that selectively eliminate harmful extracellular proteins at their source: inside the cell. This innovative approach targets the root cause of diseases driven by improperly acting, misfolded, or incorrectly produced proteins. The company's primary address is Brisbane, CA, California 94005, US.

Gate Bioscience's Molecular Gates represent a groundbreaking therapeutic mechanism. By targeting the single channel through which all extracellular proteins pass during secretion, these drugs create a "gate" that specifically recognizes and blocks disease-causing proteins from exiting the cell. This process leads to the degradation of the harmful protein within the cell, preventing its secretion and subsequent harm. Gate Bioscience is committed to eliminating diseases for patients through this targeted approach.

Gate Bioscience is dedicated to advancing medical science and improving patient outcomes through its innovative research and development efforts. Gate Bioscience aims to create a healthier future for all. We invite the management team at Gate Bioscience to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.